CHOP Researchers Develop First-Of-Its-Kind Prediction Model for Newborn Seizures
Mar 23, 2023
The model could predict which newborns would receive the most benefit from monitoring with continuous EEG to detect seizures.
Our pediatric neurologists have advanced training and experience in treating the full spectrum of neurological disorders in children and adolescents, which means the best possible care for your child.
Mar 23, 2023
The model could predict which newborns would receive the most benefit from monitoring with continuous EEG to detect seizures.
Feb 16, 2023
Patients with this complex neurological disorder experience a wide variety of symptoms, which can be managed with early and proper diagnosis.
Feb 9, 2023
STXBP1-related disorders include gastrointestional and respiratory symptoms in certain patients, according to extensive interviews with caregivers.
Jan 5, 2023
Through collaboration with research partners, patients, foundations, and community members, we are working to defeat childhood brain cancer and find better treatments for current patients. Read about recent milestones we’ve hit to accelerate pediatric brain tumor research.
Nov 29, 2022
Patients with the identified variant may respond favorably to targeted treatment with a readily available anti-seizure medication.
Sep 15, 2022
Certain patients were more likely to use telemedicine even with the reopening of in-person appointments, while barriers to telemedicine remained for some families.
Aug 2, 2022
CHOP neurosurgeons collaborated with researchers from the University of Pennsylvania School of Medicine to confirm the presence of these neurons from birth through age 92.
May 13, 2022
While telemedicine appeared to be effective in 95% of cases, some younger patients and those with neuromuscular disorders still required in-person visits.
Apr 28, 2022
Unique endocrinology-neurology collaboration seeks to understand the variation in seizure activity in patients with hyperinsulinism/hyperammonemia.
Mar 29, 2022
Recovery of normal signaling of a key brain cell may be a critical therapeutic target to reduce seizures and cognitive impairment.